
T2 Biosystems TTOO
Quartalsbericht 2024-Q3
hinzugefügt 14.11.2024
Land |
|
IPO-Jahr |
2014 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
2.61 M |
Marktkapitalisierung |
$ 313 K |
EBITDA (LTM) |
$ -45.6 M |
P/E (LTM) |
- |
P/S (LTM) |
0.04 |
EPS (LTM) |
-7.32 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Brainsway Ltd.
BWAY
|
$ 24.58 | 1.91 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
BioNano Genomics
BNGO
|
$ 1.12 | -0.88 % | $ 1.42 M | Nasdaq Capital Market,SPB | ||
|
Burning Rock Biotech Limited
BNR
|
$ 28.4 | -1.41 % | $ 306 M | Nasdaq Global Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Celcuity
CELC
|
$ 106.01 | 0.82 % | $ 4.18 B | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
DarioHealth Corp.
DRIO
|
$ 11.26 | - | $ 319 M | Nasdaq Capital Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Fulgent Genetics
FLGT
|
$ 23.02 | 0.04 % | $ 696 M | Nasdaq Global Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 209.34 | 0.95 % | $ 23.2 B | NYSE,SPB | ||
|
Castle Biosciences
CSTL
|
$ 30.02 | 3.73 % | $ 834 M | Nasdaq Global Market,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 19.18 | 2.08 % | $ 1.03 B | Nasdaq Global Market,SPB | ||
|
Danaher Corporation
DHR
|
$ 209.79 | -0.58 % | $ 153 B | NYSE,SPB | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
DexCom
DXCM
|
$ 72.99 | -0.38 % | $ 28.5 B | Nasdaq Global Select Market,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 1.74 | -5.95 % | $ 7.63 M | Nasdaq Global Select Market | ||
|
Exact Sciences Corporation
EXAS
|
$ 103.46 | 0.07 % | $ 19.5 B | Nasdaq Capital Market,SPB | ||
|
Guardant Health
GH
|
$ 96.45 | 2.15 % | $ 12.1 B | Nasdaq Global Select Market,SPB | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 287.1 | 0.62 % | $ 24.1 B | NYSE,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 166.77 | 1.98 % | $ 8.27 B | NYSE,SPB | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
ICON Public Limited Company
ICLR
|
$ 104.81 | 0.14 % | $ 8.65 B | Nasdaq Global Select Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 3.77 | 0.53 % | $ 2.02 M | Nasdaq Global Select Market | ||
|
IDEXX Laboratories
IDXX
|
$ 648.66 | 4.1 % | $ 52.2 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 123.46 | 2.42 % | $ 19.6 B | Nasdaq Global Select Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 164.94 | 1.75 % | $ 28.4 B | NYSE,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Koninklijke Philips N.V.
PHG
|
$ 31.48 | 0.82 % | $ 20 B | NYSE | ||
|
Mettler-Toledo International
MTD
|
$ 1 382.99 | -0.81 % | $ 28.5 B | NYSE,SPB | ||
|
Biodesix
BDSX
|
$ 13.28 | 3.99 % | $ 1.72 B | Nasdaq Global Market | ||
|
Quidel Corporation
QDEL
|
$ 22.06 | 4.11 % | $ 929 M | Nasdaq Global Select Market,SPB | ||
|
Natera
NTRA
|
$ 209.72 | 0.18 % | $ 20.6 B | Nasdaq Global Select Market,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 73.43 | 0.01 % | $ 5.08 B | Nasdaq Global Select Market,SPB | ||
|
Biomerica
BMRA
|
$ 2.11 | 0.49 % | $ 4.85 M | Nasdaq Capital Market | ||
|
Bioventus
BVS
|
$ 8.71 | 0.58 % | $ 546 M | Nasdaq Global Select Market | ||
|
Medpace Holdings
MEDP
|
$ 442.92 | -0.46 % | $ 12.8 B | Nasdaq Global Select Market,SPB |